This 6-year-old bull market's big winners: biotech, pharma and value stocks
We examine the problems with hedging your portfolio with inverse ETFs.
This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...
Check correlations before adding credit-sensitive fixed-income assets to your portfolio.
The views expressed do not necessarily represent the views of Acropolis Investment Management, LLC. or its members.
Also, Schwab launches Treasury ETFs.
Don't ignore these funds just because they're tiny.
The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...
Plus, Evergreen replaces subadvisor, and more.